Neurofibroma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(15 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Neurofibroma}}
{{Neurofibroma}}
{{CMG}}; {{AE}} {{SC}}
{{CMG}}; {{AE}}{{S.M.}} {{SC}}
==Overview==
==Overview==
The predominant [[therapy]] for [[neurofibroma]] is [[surgical resection]]. Adjunctive [[chemotherapy]] and [[medications]] such as [[ACE inhibitor|ACE inhibitors]] may be required.


==Treatment==
==Medical Therapy==
[[Surgical]] resection is curative, although tumors are not easily removable if they surround important nerves such as the optic nerve. There is a risk of functional damage due to interference with the [[nerve]]. [[Debulking]] may be helpful.<ref name="pmid12828709">{{cite journal |author=Babovic S, Bite U, Karnes PS, Babovic-Vuksanovic D |title=Liposuction: a less invasive surgical method of debulking plexiform neurofibromas |journal=Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] |volume=29 |issue=7 |pages=785–7 |year=2003 |pmid=12828709 |doi=}}</ref>
'''Chemotherapy'''
* Once a [[plexiform neurofibroma]] has undergone [[malignant transformation]], [[chemotherapy]] can be used as treatment<ref name="radio">Neurofibroma. Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma Accessed on November 17, 2015 </ref>
'''Radiation'''
* [[Radiation]] is generally not used as a treatment for [[plexiform neurofibroma]]s because of concerns that this could actually [[Promoter|promote]] [[malignant]] [[Transformation (genetics)|transformation]]
* There has even been a documented case of a [[schwannoma]] being induced from a [[neurofibroma]] due to [[radiation therapy]]<ref name="pmid8998885">{{cite journal |author=Isler MH, Fogaça MF, Mankin HJ. |title=Radiation induced malignant schwannoma arising in a neurofibroma |journal=Clinical Orthopaedics and Related Research  |issue=325 |pages=251–5 |year=1996 |pmid=8998885|doi=10.1097/00003086-199604000-00031 |volume=325}}</ref>
 
'''Medications'''
* [[ACE inhibitor]]s have been proposed as a novel treatment of [[Neurofibroma|neurofibromas]]<ref name="pmid18157575">{{cite journal |author=Namazi H. |title=ACE inhibitors: a novel treatment for neurofibroma |journal=Clinical Orthopaedics and Related Research |volume=15 |issue=5 |pages=1538–9 |year=2008 |pmid=18157575|doi=10.1245/s10434-007-9737-5}}</ref> 
* [[ACE inhibitor]]s are currently used to:
**Treat [[hypertension]] and [[congestive heart failure]]
**Avert remodeling and [[reinfarction]] after [[myocardial infarction]]
**Ameliorate [[diabetic nephropathy]] and other [[Renal disease|renal diseases]]
* [[ACE inhibitor]]s work by indirectly down regulating [[TGF beta|TGF-beta]], which is a [[growth factor]] that has been shown to influence the [[development]] of [[tumors]]<ref name="pmid18157575">{{cite journal |author=Namazi H. |title=ACE inhibitors: a novel treatment for neurofibroma |journal=Clinical Orthopaedics and Related Research |volume=15 |issue=5 |pages=1538–9 |year=2008 |pmid=18157575|doi=10.1245/s10434-007-9737-5}}</ref>


==References==
==References==
Line 16: Line 30:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 01:09, 29 April 2019

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma medical therapy

CDC on Neurofibroma medical therapy

Neurofibroma medical therapy in the news

Blogs on Neurofibroma medical therapy

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Shanshan Cen, M.D. [3]

Overview

The predominant therapy for neurofibroma is surgical resection. Adjunctive chemotherapy and medications such as ACE inhibitors may be required.

Medical Therapy

Chemotherapy

Radiation

Medications

References

  1. Neurofibroma. Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma Accessed on November 17, 2015
  2. Isler MH, Fogaça MF, Mankin HJ. (1996). "Radiation induced malignant schwannoma arising in a neurofibroma". Clinical Orthopaedics and Related Research. 325 (325): 251–5. doi:10.1097/00003086-199604000-00031. PMID 8998885.
  3. 3.0 3.1 Namazi H. (2008). "ACE inhibitors: a novel treatment for neurofibroma". Clinical Orthopaedics and Related Research. 15 (5): 1538–9. doi:10.1245/s10434-007-9737-5. PMID 18157575.


Template:WikiDoc Sources